Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome
- 28 July 2018
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 176 (8) , 1760-1763
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) has been shown to be related to genetic and epigenetic derepression of DUX4 (mapping to chromosome 4), a gene located within a repeat array of D4Z4 sequences of polymorphic length. FSHD type 1 (FSHD1) is associated with pathogenic D4Z4 repeat array contraction, while FSHD type 2 (FSHD2) is associated with SMCHD1 variants (a chromatin modifier gene that maps to the short arm of chromosome 18). Both FSHD types require permissive polyadenylation signal (4qA) downstream of the D4Z4 array.Keywords
This publication has 12 references indexed in Scilit:
- Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2European Journal of Human Genetics, 2017
- De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal developmentNature Genetics, 2017
- Genetic and epigenetic contributors to FSHDCurrent Opinion in Genetics & Development, 2015
- Hemizygosity forSMCHD1in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion SyndromeHuman Mutation, 2015
- Whole‐body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophyMuscle & Nerve, 2015
- Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriersNeurology, 2014
- Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2Neuromuscular Disorders, 2013
- A focal domain of extreme demethylation within D4Z4 in FSHD2Neurology, 2013
- Monosomy 18p and immunologic dysfunctionClinical Dysmorphology, 2011
- Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular DystrophyThe American Journal of Human Genetics, 2007